CYCLOPENTHIAZIDE

Details

Stereochemistry	RACEMIC
Molecular Formula	C13H18ClN3O4S2
Molecular Weight	379.883
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

NS(=O)(=O)C1=C(Cl)C=C2NC(CC3CCCC3)NS(=O)(=O)C2=C1

InChI

InChIKey=BKYKPTRYDKTTJY-UHFFFAOYSA-N

InChI=1S/C13H18ClN3O4S2/c14-9-6-10-12(7-11(9)22(15,18)19)23(20,21)17-13(16-10)5-8-3-1-2-4-8/h6-8,13,16-17H,1-5H2,(H2,15,18,19)

HIDE SMILES / InChI

Molecular Formula	C13H18ClN3O4S2
Molecular Weight	379.883
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/chlorothiazide

Cyclopenthiazide is a thiazide diuretic. It inhibits the Na+-Cl− symporter in the distal convoluted tubule of the kidney. Cyclopenthiazide is used for the treatment of edema, including that associated with heart failure, and for the treatment of hypertension.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Solute carrier family 12 member 3 3 Target ID: P55017 Gene ID: 6559.0 Gene Symbol: SLC12A3 Target Organism: Homo sapiens (Human) Sources: https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/chlorothiazide	Inhibitor 8297

Conditions

Condition	Modality	Highest Phase	Product
Hypertension 567 Sources: https://imedi.co.uk/navidrex-0-5mg-tablets	Primary	Approved 8429	NAVIDREX Approved Use Navidrex® 0.5mg Tablets are used to treat high blood pressure and some types of heart problems. They are also used to help reduce fluid retention associated with the pre-menstrual syndrome and some kidney or liver diseases.
Edema 22 Sources: https://imedi.co.uk/navidrex-0-5mg-tablets	Primary	Approved 8429	NAVIDREX Approved Use Navidrex® 0.5mg Tablets are used to treat high blood pressure and some types of heart problems. They are also used to help reduce fluid retention associated with the pre-menstrual syndrome and some kidney or liver diseases.
Heart failure 103 Sources: https://imedi.co.uk/navidrex-0-5mg-tablets	Primary	Approved 8429	NAVIDREX Approved Use Navidrex® 0.5mg Tablets are used to treat high blood pressure and some types of heart problems. They are also used to help reduce fluid retention associated with the pre-menstrual syndrome and some kidney or liver diseases.

PubMed

Title	Date	PubMed
Effect of long-term diuretic treatment on body-potassium in heart-disease.	1976 Nov 13	62899
Enalapril-related cholestatic jaundice.	1990 Apr	2342045

Sample Use Guides

In Vivo Use Guide

The usual adult dose is half of one tablet (0.25 mg) , or one whole tablet (0.5 mg) a day, alone or with other medicines.

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:20:59 GMT 2023` Edited by `admin` on `Fri Dec 15 16:20:59 GMT 2023`
Record UNII	VX4S2N85F5
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CYCLOPENTHIAZIDE

Official Name

English

CYCLOPENTHIAZIDE [MI]

Common Name

English

cyclopenthiazide [INN]

Common Name

English

6-Chloro-3-(cyclopentylmethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

Systematic Name

English

CYCLOPENTHIAZIDE [JAN]

Common Name

English

SU-8341

Code

English

CYCLOPENTHIAZIDE [USAN]

Common Name

English

NSC-107679

Code

English

NAVIDREX

Brand Name

English

Cyclopenthiazide [WHO-DD]

Common Name

English

CYCLOPENTHIAZIDE [MART.]

Common Name

English

2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE, 6-CHLORO-3-(CYCLOPENTYLMETHYL)-3,4-DIHYDRO-, 1,1-DIOXIDE

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C49185